Tech Stock News
Wednesday, March 29, 2023
Adamis Pharmaceuticals Corporation (NASDAQ: ADMP) dropped 1.96% after the company announced that start-up activities for the clinical trial of its experimental COVID-19 treatment, Tempol, are underway. The company is conducting the activities in collaboration with an extensive clinical research organization. Adamis commence activities on a COVID-19 treatment study Already, site […]
Adamis Pharmaceuticals Corporation (NASDAQ: ADMP) gained 6.93% following the announcement that the FDA had accepted to review its resubmitted New Drug Application for ZIMHI™. ZIMHI is a higher naloxone injection product candidate under development by the company for opioid overdose treatment. It lost 5.56% in the last trading session. The […]